Pheochromocytoma is a tumor of the adrenal medulla for which surgical resection is the only therapy. Though the Notch1 signaling pathway has been suggested as a target for pheochromocytoma treatment, the effect of Notch1 intracellular domain (NICD) on pheochromocytoma cell growth remains unknown. In the present study, the effect of NICD on pheochromocytoma cell growth was examined, by use of a tetracycline-inducible system for NICD overexpression in the PC12 pheochromocytoma cell line. Flow cytometry was used to determine the effect of NICD on cell cycle phase distribution and apoptosis in PC12 cells. Protein expression levels of microtubule associated protein 1 light chain 3 B (LC3B), Beclin 1, autophagy-related (ATG) 5 and ATG7 were examined using western blot analysis. Untreated PC12 cells lack NICD expression, while treatment with doxycycline resulted in a significant NICD overexpression. NICD overexpression promoted cell apoptosis and suppressed cell proliferation via regulating S-phase arrest. In addition, NICD overexpression stimulated the expression of autophagy-related proteins LC3B, Beclin 1, ATG5 and ATG7. In conclusion, NICD promoted cell apoptosis, suppressed cell proliferation, and stimulated autophagy-related protein expression in PC12 cells. The present data indicate that overexpression of NICD may be a promising potential therapy for pheochromocytoma.
Introduction
Although the incidence of pheochromocytoma is only two cases per million of the global population (1) , it leads to hypertension and life-threatening cardiovascular complications (2) . Pheochromocytoma, located in the adrenal medulla, is a chromaffin cell neoplasm that secretes catecholamines and various hormones, including norepinephrine, epinephrine, dopamine, and chromogranin A. These vasoactive hormones are responsible for the classical triad of symptoms in pheochromocytoma: Episodic headache, sweating, and palpitations (3) . Due to the catecholamine-secreting nature of pheochromocytomas, the diagnostic biochemical tests for these tumors involve detection of these hormones. However, no effective treatment exists for this tumor. With drug therapy having no significant long-lasting benefit, operative treatment is the only definitive cure (4, 5) . Therefore, it is important to explore the mechanism underlying pheochromocytoma pathogenesis and to investigate novel and improved treatment methods for pheochromocytomas.
The Notch1 signaling pathway is a highly-conserved pathway that serves important roles in cell fate specification, differentiation, proliferation and survival (6) (7) (8) . Notch1 is a transmembrane receptor protein that is activated by binding to the delta-like protein 1 ligand, which results in a double proteolytic cleavage of the Notch1 protein (9) . The first proteolytic cleavage is mediated by a metalloprotease in the Notch extracellular domain, followed by the second cleavage by the γ-secretase complex in the transmembrane domain. Notch1 intracellular domain (NICD) then translocates from the cytoplasm to the nucleus and binds with the recombination signal binding protein for immunoglobulin κ J region and other DNA binding complexes to regulate expression of genes, including hes family bHLH transcription factor 1 (HES1), cyclin D and hes related family bHLH transcription factor with YRPW motif 1 (10, 11) . Pheochromocytoma cells do not express active Notch1, but Notch1 activators, valproic acid and suberoyl bis-hydroxamic acid, have been reported to inhibit growth and limit hormonal secretion by pheochromocytoma cells (12) . However, the function of NICD in pheochromocytoma cells remains unclear.
In order to investigate the role of NICD in pheochromocytoma, a tetracycline-inducible system for NICD overexpression in the PC12 pheochromocytoma cell line was employed. The present study tested the hypothesis that overexpression of NICD in PC12 cells may influence tumor cell growth.
Materials and methods
Cell culture. Rat PC12 cells were cultured in a humidified atmosphere of 5% CO 2 at 37˚C in high-glucose Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), supplemented with 10% fetal calf serum (HyClone; GE Healthcare Chicago, IL, USA), 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were subcultured every 2-3 days. The control and PC12-NICD cell lines were constructed by stable transfection of the tet-on-EGFP and tet-on-EGFP-NICD plasmids respectively, as described previously (13) .
Cell morphology observation. PC12 cells were treated with 500 µg/ml doxycyclin (Dox) for 36 h at room temperature and cell nuclei were stained with DAPI at 0 and 36 h. The cells were then observed using an inverted fluorescence microscope (IMT-2; Olympus Corporation, Tokyo, Japan) and cell images were captured using a charge-coupled device camera attached to the microscope.
Flow cytometry. Cells were cultured and treated with Dox for 36 h. Cells were then trypsinized, washed twice with PBS, and incubated with phycoerythrin (PE)-conjugated monoclonal anti-Notch1 antibody (cat. no. 559763; 1:50; BD Biosciences, Franklin Lakes, NJ, USA), which can also recognize NICD, for 30 min at 4˚C in the dark. The cells were washed twice with PBS, fixed with 4% formaldehyde in PBS and centrifuged. Cells were analyzed using a FACSCanto II (BD Biosciences). A 488 nm wavelength laser was used to excite enhanced green fluorescent protein (EGFP) and PE and fluorescence signal was acquired on the FL1 and FL2 spectral detection channels, respectively. Results were analyzed with BD FACS Data-Interpolating Vibrational Analysis software version 5.0 (BD Biosciences).
Apoptotic cells detection. Apoptosis was detected by
Annexin V-Phycoerythrin (PE) and 7-Amino-Actinomycin (7-AAD) staining followed by flow cytometric analysis. The staining was preformed using an Annexin V-PE Apoptosis Detection kit (cat. no. 559763; BD Biosciences), following the manufacturer's protocol. The cells were resuspended in 400 µl 1X binding buffer at a concentration of 1x10 6 cells/ml, and then incubated with 5 µl Annexin V-PE and 5 µl 7-AAD for 15 min at room temperature in the dark. Finally, the cells were analyzed by flow cytometry.
Cell cycle assay. Cell cycle phase distribution was assessed in order to evaluate cell proliferation in PC12 cells. Cells (1x10 6 ) were collected and washed with ice-cold PBS, then fixed in ice-cold 70% ethanol at -20˚C for 24 h. The fixed cells were centrifuged at 1,000 x g for 5 min, washed twice with PBS, resuspended in PBS and incubated with 500 µl PI (cat. no. 550825; BD Biosciences) at 4˚C for 30 min. Finally, the cells were analyzed by flow cytometry.
Western blotting. Following washing with cold PBS three times, cells were lysed in radioimmunoprecipitation assay buffer (150 mM NaCl, 10 mM Tris-HCl pH 7.4, 0.5% Triton X-100 and protease inhibitors; Merck KGaA), homogenized on ice, and centrifuged at 12,000 x g at 4˚C for 15 min. The supernatant was collected and stored at -80˚C until use. Protein concentration was determined using a bicinchoninic acid assay kit (Pierce; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Total proteins (25 µg) were separated on 12% tris-polyacrylamide gel. The proteins were then transferred to nitrocellulose membranes (EMD Millipore, Billerica, MA, USA). The membranes were blocked in 5% non-fat dry milk for 1 h at 37˚C, washed in TBS with 0.05% Tween-20 (TBST) and incubated overnight with mouse primary antibodies targeting microtubule associated protein 1 light chain 3 B (LC3B), Beclin1, autophagy-related (ATG)5 and ATG7 (cat. nos. 3868, 3495, 12994 and 8558; 1:1,000; Cell Signaling Technology, Inc., Danvers, MA, USA;) at 4˚C. Mouse anti-β-actin (cat. no. sc-47778, 1:1,000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA.) was used as an internal control. The membranes were washed thrice in TBST and incubated for 1 h with secondary antibodies conjugated to horseradish peroxidase (HRP) (cat. no. SC-2004; 1:2,000; Santa Cruz Biotechnology, Inc.) at 37˚C, washed thrice in TBST, and treated with Immun-Star HRP peroxide buffer and Luminol/Enhancer (Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China) for chemiluminescent detection of protein bands. The computer gray-scale value was analyzed using Quantity One software version 4.6.2 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Statistical analysis. Data were analyzed using SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA) and were presented as the mean ± standard deviation. Significance analysis was performed using Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
Results

Dox treatment induces NICD expression in PC12 cells.
A tetracycline (tet)-inducible system was used to drive overexpression of NICD in PC12 cells. PC12 cells were transfected with either a tet-on-EGFP plasmid (control) or a NICD-expressing tet-on-EGFP-NICD plasmid (NICD), and protein expression was then induced with Dox. EGFP fluorescence was assessed in the Dox-induced PC12 cells at 36 h and it was observed that 90.4% of the total cells were EGFP-positive in the NICD group (Fig. 1A) . Next, NICD expression was examined by staining with a PE-conjugated specific antibody and flow cytometry analysis. PE fluorescence was significantly enhanced following induction with Dox for 36 h (Fig. 1B and C) . These results establish that NICD was overexpressed in the PC12-NICD cells at 36 h post-induction with Dox.
Overexpression of NICD increases PC12 cell apoptosis.
To investigate the effect of NICD overexpression on apoptosis, PC12 cells were induced with Dox for 36 h and then double-stained with Annexin V and PI prior to flow cytometry analysis. PC12 cells in which NICD was overexpressed exhibited an increased apoptosis rate compared with control cells (Fig. 2) .
Overexpression of NICD inhibits PC12 cell proliferation.
To investigate the effect of NICD overexpression on PC12 cell proliferation, cell cycle analysis was performed. PC12 cells were induced with Dox for 36 h, stained with PI and then analyzed by flow cytometry for cell cycle phase distribution. The results indicated that the % of cells in the S-phase of the cell cycle was suppressed in the NICD group compared with the control group, which suggested that NICD overexpression significantly inhibited the growth of PC12 cells via regulating S-phase cell cycle arrest (Fig. 3) .
NICD overexpression influences autophagy-related protein expression.
To evaluate the effect of NICD on autophagy, the protein expression levels of autophagy-related proteins ATG5, ATG7, LC3B and Beclin1 were analyzed by western blotting in cells that were induced with Dox for 36 h. The results demonstrated that Dox-induced NICD expression significantly increased the level of LC3II/I ratio, and the expression levels of ATG5, ATG7 and Beclin1 compared with the group (Fig. 4) . These results suggested that NICD may be involved in regulating PC12 cell growth in part through autophagy-dependent pathways.
Discussion
Notch signaling served an important role in cell fate specification, differentiation, proliferation, and survival (14) . Previous studies have demonstrated that Notch signaling is significant in neurogenesis (15) . Increased expression of active Notch1 protein inhibits cell growth and hormone secretion in carcinoid norepinephrine tumors and medullary thyroid cancer cells (16, 17) , and Notch1 activator/histone deacetylase inhibitor compounds lead to a decrease in proliferation in PC12 cells (12) . In another study, treatment with the Notch1 signaling pathway inhibitor N-[N-(3,5-difluorophenacetyl)-Lalanyl]-S-phenylg lycinet-butyl ester and with the amyloid-β peptide 25-35, resulted in prolonged survival and decreased expression of caspase 3, 8 and 9 in PC12 cells (18) . However, the function of NICD in pheochromocytoma remains unknown.
In order to explore the role of NICD in pheochromocytoma, a tet-inducible system for NICD expression in the PC12 cell line was used. Through transfection and drug selection, PC12 cells expressing tet-inducible NICD (PC12-NICD cells) were obtained, in which NICD expression is under a tight regulation by Dox (13) . At 36 h post-Dox induction, NICD protein expression levels were significantly enhanced in the PC12-NICD cells compared with the control cells. The results demonstrated that NICD overexpression suppressed cell proliferation and increased the rate of apoptosis in PC12 cells.
Autophagy is an intracellular degradation system that delivers proteins and organelles to the lysosome and provides cells with nutrients by recycling the degradation products (19) (20) (21) . Mutants of the Notch gene, glp-1, lead to inhibition of germline proliferation and to increase in autophagy levels in the nematode Caenorhabditis elegans (22, 23) . Another study on T-cell leukemia reported that activation of the Notch target gene HES1 regulates the expression of phosphatase and tensin homolog (24) . Inhibition of Notch signaling increases autophagy activity. Autophagy has been reported to occur downstream of the Notch pathway receptor activation during Drosophila melanogaster zygote development, and a decrease in autophagy resulted in precocious activation of Notch signaling in ovarian follicle cells (25) . These studies suggest a link between Notch signaling and autophagy, that remains to be elucidated. In the present study, expression levels of autophagy-related proteins LC3B, ATG5, ATG7 and Beclin 1 were significantly increased in PC12 cells following overexpression of NICD, which implied that NICD, a fragment of the Notch1 protein, is sufficient to induce autophagy in PC12 cells. Whether NICD-mediated autophagy contributes to suppressed cell proliferation and increased apoptosis needs to be further explored in the future. Recently, Wu et al (26) reported that developmental retention of early-stage cells and the differentiation of stem cells is delayed in the Atg16L1 mutation mouse model, which suggests that autophagy regulates Notch degradation and modulates stem cell development and neurogenesis.
In summary, the present study indicated that overexpression of NICD suppressed cell proliferation, promoted cell apoptosis, and activated increased autophagy-realted protein expression in PC12 cells. The present results suggest that NICD may be a promising target towards developing novel and effective treatment strategies against pheochromocytoma.
